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The relevance for in vitro three-dimensional (3D) tissue culture of skin has been present for
almost a century. From using skin biopsies in organ culture, to vascularized organotypic
full-thickness reconstructed human skin equivalents, in vitro tissue regeneration of 3D
skin has reached a golden era. However, the reconstruction of 3D skin still has room
to grow and develop. The need for reproducible methodology, physiological structures
and tissue architecture, and perfusable vasculature are only recently becoming a reality,
though the addition of more complex structures such as glands and tactile corpuscles
require advanced technologies. In this review, we will discuss the current methodology
for biofabrication of 3D skin models and highlight the advantages and disadvantages of
the existing systems as well as emphasize how new techniques can aid in the production
of a truly physiologically relevant skin construct for preclinical innovation.
Keywords: 3D tissue model, skin, in vitro, bioprinting, electrospinning, skin disease, biofabrication, preclinical
testing
INTRODUCTION
Skin Structure and Function
The body’s primary barrier against many environmental exposures, including organisms and
chemicals, the skin, is the largest organ of the human body covering an area of ∼2m2. The skin
consists of three layers, from inner to outermost: hypodermis, dermis, and epidermis (Figure 1),
each of which has a unique structure, composition and synergistic function. The hypodermis,
also known as the subcutaneous tissue (adipocytes, nerves and blood vessels), functions as an
insulator, shock absorber, and nutrient reservoir. The dermis, the thick fibrous layer, is partitioned
into two sub-layers, the papillary and reticular dermis, although there is no sharp delineation
between these layers. These layers consist of fibers (elastin and collagen) and glycosaminoglycans
(GAGs), as well as many cell types (fibroblasts, dermal dendrocytes, mast cells, and histiocytes).
Macrostructures found in this layer include blood vessels, lymphatics, and appendages (sebaceous,
apocrine and eccrine glands, hair follicles and arector pili muscle, nerves and tactile corpuscles, and
nails). The dermis functions as an insulator, mechano- and thermosensor, immunologic defense,
as well as maintains proper hydration. Lastly, the outermost layer of the skin, the epidermis,
consists of five stratified sublayers (from inner to outermost: stratum basale, stratum spinosum,
stratum granulosum, stratum lucidum, and stratum corneum) consisting predominantly of
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FIGURE 1 | Healthy skin structure: layers, sublayers, and appendages/macrostructures. The skin consists of three main strata, from bottom to top: hypodermis,
dermis, and epidermis. The hypodermis, also known as the subcutaneous tissue, is comprised of adipocytes within a mesh of connective tissue through which nerves
and blood vessels traverse. Above the subcutaneous tissue is the dermis, a thick fibrous layer partitioned into two sub-layers, the papillary dermis and the reticular
dermis. The dermis is primarily comprised of a fibrous scaffold within which fibroblasts, dermal dendrocytes, mast cells, and histiocytes can be found. Additionally,
blood vessels, lymphatic networks, glands, hair follicles, and tactile corpuscles reside here. Above the dermis, the outermost stratum is the epidermis. The epidermis
consists of five substrata: the stratum basale, stratum spinosum, stratum granulosum, stratum lucidium, and stratum corneum from deepest to most superficial. The
cellular constituents of the epidermis are predominantly keratinocytes, though Langerhans cells, Merkel cells, and melanocytes can also be found in this layer.
keratinocytes, whereas Merkel cells, Langerhans cells, and
melanocytes combined contribute to 5% of the cell population
(Zaidi and Lanigan, 2010). The epidermis functions as a physical
barrier, immune defense, and mechanosensor. All too often, the
complexity of skin is simplified for in vitro experimentation,
yet the complete structure and function of the skin as an organ
is dependent on all layers, cells, and appendages, for proper
function.
From 2D to 3D Models: The Rationale
Current in vitro pathophysiological studies are conducted
primarily in two-dimensional (2D) cell culture in which cells are
grown as a monolayer on solid flat surfaces such as polystyrene
or glass. This 2D system relies on a fluid medium that supplies
the essential nutrients (amino acids, carbohydrates, vitamins,
minerals), growth factors, hormones, gases (O2 and CO2) and
that regulates the physical-chemical environment (pH, osmotic
pressure, temperature) (Antoni et al., 2015). Although these
2D cell culture systems have played a key role in furthering
our understanding of molecular signaling, cellular morphology,
and drug discovery, not all results and conclusions from these
2D cell culture systems are translatable to physiological in vivo
systems (Duval et al., 2017; Langhans, 2018). Additionally,
2D monolayers specifically lack the environmental factors (e.g.
mechanical forces, spatial orientation, as well as physiological
oxygen, nutrient and signaling gradients) associated within the
three-dimensional (3D) in vivo environment. Moreover, cell-
to-cell, cell-to-matrix, and cell-to-environment interfaces are
important for physiologically relevant cell functions and the
absence of these critical factors, such as that in 2D cell culture,
impact cellular responses from morphology, proliferation,
migration, and differentiation, to biochemical signaling as well as
gene and protein expression (Ali et al., 2015; Antoni et al., 2015).
The abovementioned limitations of 2D cell culture models
as unreliable predictors of in vivo drug efficacy and toxicity are
further supported by the relative high drug failure rate during
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preclinical testing for diseases such as cancer (Hutchinson and
Kirk, 2011; Boghaert et al., 2017). As a result, physiological
3D skin models are required to provide a better platform for
predicting clinical outcomes for drug testing. One approach,
“organ culture,” is the culturing of 3D human skin biopsies
ex vivo. Although organ culture offers the ideal physiological
construct, the practicality of its use is substandard due to limited
tissue availability (specifically diseased tissue biopsies), donor-
donor variability, and ethical considerations.
A Brief History of in vitro 3D Skin Models
In the middle of the twentieth century, just prior to the
standardization of nutrient media, the culturing of 3D human
skin biopsies ex vivo began (Medawar, 1948). Soon after, in the
1950’s and −60’s, the development of mixed- and single-type
primary 2D cell cultures, including that of human keratinocytes
(Wheeler et al., 1957), would prevail as standard lab practice
over organ culture and 3D cell culture. Although 2D culture was
simple and reproducible (Wheeler et al., 1957), the relevance for
3D constructs was evident (Ehrmann and Gey, 1956), and in
the late 1970’s a “living skin equivalent” implementing a dermis-
like collagen hydrogel was described (Bell et al., 1979, 1981a,b).
Further technical advances in the 80’s and 90’s, specifically
electrospinning, would lead to the use of scaffolds for 3D cell
culture (Li et al., 2002). Moreover, at present in the twenty-
first century, with the implementation of 3D printing for use in
biological applications (Lee et al., 2009), the simple hand-poured
hydrogel matrix will become a relic, setting a new standard for
the production of 3D tissue constructs.
This review aims to (1) describe the current methodology of
3D skin fabrication to date as well as the advantages, and
limitations of the current techniques, and (2) to emphasize how
advanced biofabrication techniques can drive the progression
toward developing the next stage of reproducible and complex,
physiologically relevant, 3D skin constructs for personalized
medicine.
PHYSIOLOGICAL SKIN MODEL IN 3D
In the modern age, it is crucial to develop 3D skin models.
This notion is supported by an expanse of literature that
demonstrates that cells respond more physiologically in 3D
culture as compared to 2D (Hoarau-Vechot et al., 2018).
Specifically, the biochemical signals, mechanical and structural
properties of 3D constructs nearly resemble in vivo physiology.
Moreover, primary skin-derived cells cultured in 3D systems
not only mimic the in vivo environment, but also allow for
personalized mechanistic and translational studies. Currently,
twomain types of engineered 3D tissuemodels exist: (1) Scaffold-
free and (2) Scaffold-based.
Scaffold-Free 3D Models
Scaffold-free models of 3D tissues, spheroids, are defined as
non-adherent cell aggregates produced by the self-assembly of
one or more cell types. Spheroids, also called microtissues, self-
assemble by gravity force from monodispersed cells and replicate
many features of organ and tumor tissues including deposition
of extracellular matrix (ECM) proteins, cell-cell interactions,
as well as the formation of nutrient, waste and gas (O2 and
CO2) gradients (Hirschhaeuser et al., 2010). Using a scaffold-
free 3D skin model is advantageous, due to low costs and
reproducibility; such models are suitable for high throughput
cellular function, cytotoxicity, or biochemical analyses. However,
to obtain proper tissue architecture, the positioning of the cells
dictates the production of a full thickness stratified epidermis.
The production of spherical skin microtissues with different
keratinocyte layers and a dermal fibroblasts core producing
the ECM was described recently (Stroebel et al., 2016). Still,
this model mimics skin tissue on a micro-scale and is fully
immersed in media, which does not recapitulate the air-
liquid-interface of physiological skin and in turn may affect
compound penetration and action. Thus, an ideal skin equivalent
should function as a physical barrier at the interface with a
gaseous environment. The skin barrier is strongly dependent
on the humidity and culture conditions in which it is created
(Asbill et al., 2000). Though scaffold-free approaches for the
production of micro-tissues are high throughput-compatible,
the main application lies in anti-cancer drug development
and toxicology assessment (Messner et al., 2013; Sant and
Johnston, 2017). However, spheroids have been used to study
skin cancer by the integration of melanoma cancer spheroids
placed into skin equivalents (Vorsmann et al., 2013). In this
respect, bioprinting offers the possibility to standardize the
deposition of micro-tissues by the exact positioning of spheroids
in the raised skin models (Jakab et al., 2010; Moldovan et al.,
2017).
Scaffold-Based 3D Models: Natural or
Synthetic Polymers and Polymer
Combinations
Scaffold models of 3D tissues, when defined broadly, are cells
grown in the presence of support scaffolds, either hydrogel-
based support, or polymeric fiber-based support. These scaffolds
can be comprised of natural, synthetic, or combinations of
different polymers, and unlike scaffold-free models, represent a
3D construct that is structurally, mechanically and functionally
similar to the biological tissue (Debels et al., 2015; Caddeo et al.,
2017).
Natural polymers such as collagen, fibronectin, elastin, fibrin,
silk, alginate, chitosan, fibrin, or GAGs (Mason et al., 2013;
Lohmann et al., 2017), are typically non-cytotoxic and seldom
illicit an inflammatory response, hence making them prime
candidates for cell-laden in vitro 3D skin models. Collagen type
I, as the primary component of dermal extracellular matrix
(ECM), is the most commonly used natural polymer constituent
in bioengineered skin. Specifically, the ability to extract collagen
from natural sources makes it an attractive and physiologically
relevant matrix candidate. Unfortunately, collagen and other
biopolymers typically have weak mechanical properties due
to the very high water content. For instance, collagen I is
susceptible to physical contraction when integrated fibroblasts
exert forces on the matrix (Moulin et al., 1996). This contraction
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is diminished by the removal of water from the scaffold
by physical compression (Vidal et al., 2018). Furthermore,
these hydrogels are prone to enzymatic degradation, e.g. by
collagenases (MMP2, MMP9) and further by gelatinases, making
them unstable for long-term cell culture (Karsdal et al., 2017).
Additionally, some of the degradation products can induce
chemotaxis of human fibroblasts (Chattopadhyay and Raines,
2014). Nevertheless, collagen-based bioengineered skin tissues
are still the most commonly employed models to mimic both
healthy and diseased skin in vitro. For that reason, additional
techniques are implemented to improve the mechanical strength
of natural scaffolds such as cross-linking. Common cross-linking
techniques include either chemical cross-linking, using reactive
components such as glutaraldehyde, or the amalgamation of
natural products such as GAGs or fibrin (Brougham et al.,
2015). An additional method utilized to stiffen naturally-
derived collagen hydrogels is non-enzymatic glycation, whereby
proteins are cross-linked by reducing sugars (such as glucose)
during several chemical modifications (Mason et al., 2013).
The disadvantage of this method is that the excess of sugar
produces a cytotoxic hyperosmotic environment preventing
the incorporation of cells during gel formation. Therefore,
another tactic to enhance the biological and mechanical
properties of scaffold models is the combination of two or
more natural polymers. A hydrogel produced from cross-
linked silk and collagen was described as an ideal dermal
biomaterial (Vidal et al., 2018). This combination allows for
the preservation of cell-binding domains from collagen while
benefitting from the stabilizing properties of silk, which proved to
bemore resistant to time-dependent degradation and contraction
when compared to collagen hydrogels. Moreover, the use of
advanced biofabrication techniques, such as electrospinning
and bioprinting, may also diminish the problems associated
with contraction and chemical cross-linking. In 2018, de
Torre et al. described electrospinning of clickable elastin-like
recombinamers that do not require addition of potentially
cytotoxic cross-linkers, while allowing for the incorporation
of different functionalities (i.e. RGD motifs) to support cell
adhesion and proliferation (Gonzalez de Torre et al., 2018). As
outlined in this section many different biopolymers were used
and developed to generate 3D skin models; however, collagen
I, with the abovementioned limitations, is still predominantly
used (Sahana and Rekha, 2018).
Besides the potential for correcting problems associated with
hydrogel contraction and chemical cross-linking, bioprinting
also permits the direct integration of cells, bioactive molecules
and scaffold material, mainly hydrogels, in a layer-by-layer
mode (Mironov et al., 2006). Initially, the scaffold materials
used to bioprint hydrogels, with the ability to support 3D
cell growth, included the natural polymers collagen I, alginate,
or Matrigel R© (Malda et al., 2013), and thus the term
“bioink” was coined. Currently, three main technologies for the
production of bioprinted tissues are employed: (1) laser-assisted
bioprinting (LaBP), (2) inkjet-based, and (3) micro-extrusion-
based bioprinting (Malda et al., 2013; Murphy and Atala, 2014;
Ng et al., 2016; Huang et al., 2017; He et al., 2018). Advancements
in bioprinting led to the development of tailor-made bioinks
that provide optimal printing properties while maintaining
cell-compatibility (Gungor-Ozkerim et al., 2018). Furthermore,
bioprinting offers the possibility to co-print biomaterials with
different mechanical properties to increase the scaffold’s stability
(Shim et al., 2011). With respect to bioprinting skin constructs,
mainly natural-derived polymers are used. In 2017, Pourchet
and colleagues printed a mixture of gelatin, alginate, and fibrin
to generate a full-thickness skin model with a characteristic
stratified epidermis (Pourchet et al., 2017). Lee et al. printed
collagen I together with human primary dermal fibroblasts and
epidermal keratinocytes in layers using an inkjet-based approach
and demonstrated high cell viability (Lee et al., 2009). While
these constructs did not possess a stratified epidermis, this
could be improved with a combined air-liquid interface (ALI)
approach (Lee et al., 2014). In the following years, othermaterials,
such as photo-crosslinkable gelatin-methacryloyl (GelMA), were
implemented with primary dermal fibroblasts and epidermal
keratinocytes in ALI culture, resulting in full-thickness skin
models with an epidermal-like structure, however this model
did not fully recapitulate a stratified epidermis (Rimann et al.,
2016). In order to increase the mechanical stability of the bioink,
GelMA was mixed with collagen I and the enzyme tyrosinase
(Ty). With this approach, Shi et al. (2018) could demonstrate
not only increased mechanical stability of the Ty-crosslinked
construct, but also an improved skin regeneration process.
Nevertheless, a full thickness skin model was not present in this
study.
Due to the poor mechanical properties and high batch-to-
batch variability observed with natural polymers, synthetic
polymers were developed (Antoine et al., 2014) including
polyesters such as poly(ε-caprolactone) (PCL), polylactic
acid, polyglycolic acid, polylactic-co-glycolic acid (PLGA),
polyhydroxybutyrate, and polyethers such as polyethylene glycol
(PEG) and PEG co-polymers. The advantages of using synthetic
polymers resides in their adjustable physical properties (e.g.
porosity, biodegradation, and stiffness/elasticity) to suit specific
applications. PCL, for example, was used for the production
of tissue scaffolds by both classical electrospinning (Sharif
et al., 2018) and melt-electrospinning (Farrugia et al., 2013),
in which a high porosity and interconnectivity promote
cell invasion and synthesis of both collagen type I and
fibronectin. Thus, electrospinning has been advantageous
for the cost-effective production of scaffolds with large surface
areas and high porosities that permit the fabrication of
nanofibrous 3D skin models containing a matrix that bears
high similarity to the native ECM (Wang et al., 2013). However,
since synthetic polymers typically have poor cell adhesive
properties they are regularly used in combination with natural
polymers.
To circumvent the adhesive issues with synthetic polymers,
natural-synthetic polymer combinations are used. Recently,
studies fabricating collagen hydrogels cross-linked with PEG
have demonstrated diminished contraction of hydrogels
while maintaining cell viability of embedded primary
dermal fibroblasts (Brougham et al., 2015; Lotz et al.,
2017). Unfortunately, the cytotoxicity of chemical-crosslinked
synthetic products such as glutaraldehyde or PEG is debatable
(Vedadghavami et al., 2017; Rahmani Del Bakhshayesh
et al., 2018). On the other hand, natural-synthetic polymer
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combinations have been tested with electrospinning. For
instance, silk fibroin, a material known for its biocompatibility,
yet comparatively good mechanical properties (Lee et al., 2014;
Sheikh et al., 2015), was recently combined with PCL resulting
in composites that possess a surface topography and chemistry
that promoted fibroblast-induced collagen deposition (Lee et al.,
2016b). Despite the attempts to improve hydrogel properties
with the development of synthetic polymers, natural polymers
appear to be essential for physiological significance of 3D
constructs.
Appendages and Macro-Structures
In addition to the structural and mechanical components
of 3D tissue constructs, the inclusion of appendages and
macrostructures such as vasculature and glands (Figure 1), is
important for modeling physiological functions. A classical
approach is the use of sacrificial polymers (e.g. gelatin, agarose,
pluronic F-127) that are printed into a bulk hydrogel for later
removal from themainmatrix [e.g., collagen I, photopolymerized
poly-(ethylene glycol) diacrylate], followed by perfusion of the
produced channels in a subtractive manufacturing approach (Lee
et al., 2010; Bertassoni et al., 2014). Over the past 4 years, the
expansion of biofabrication techniques has aided production of
vessels including bioprinting (Kolesky et al., 2014; Bibb et al.,
2016), subtractive manufacturing with sacrificial electrospun
polymers (Lee et al., 2016a) as well as many other approaches
which are summarized in a review by Frueh et al. (2017). In fact,
3D skin constructs produced with vascular (Marino et al., 2014)
and lymphatic networks (Marino et al., 2014; Gibot et al., 2017)
are possible. Moreover, a commercially available vascularized
skin model, Skin-VaSc-TERM R© (ATERA SAS, France) is also in
production. Despite these advances, there are major limitations
for vascularization in 3D constructs including vessel diameter,
reproducibility, adaptability, and the development of suitable
perfusion culture conditions. Further combining and evolving of
today’s biofabrication techniques such asmelt-electrospin writing
(MESW) and 3D bioprinting could provide ameans of producing
microvasculature at the capillary scale (1–2µm) and with precise
placement of vessels in a reproducible manner. This allows for
the controlled fabrication of duplicates from which comparisons
can be made with respect to in vitro therapeutic screening,
as well as the assessment of wound dressings, an application
currently lacking an in vitro screening process. Furthermore, the
production of macro-structures such as glands (i.e. sweat glands
and sebaceous glands), tactile corpusicles, and hair are the next
step toward a truly physiological skin model (Takagi et al., 2016).
Although the in vitro growth of sebocytes (Barrault et al., 2012),
eccrine glands (Klaka et al., 2017; Poblet et al., 2018), and hair
follicles (Lee et al., 2018) has been tested in 3D, the biofabrication
of these glands in reproducible constructs would be far superior
with bioprinting (Huang et al., 2016). Overall, the biofabrication
of thesemacro-structures are limited (Liu et al., 2016) and require
further advancement to produce a physiological 3D skin model.
Outlook of Physiological 3D Skin Models
Although optimization of hydrogel fabrication is evident, there
is, as of yet, no ideal bioink to produce the physiologically
relevant hydrogel to mimic the structural, mechanical, and
biochemical properties of actual skin. Thus, additional focus
on hydrogel composition is necessary. Exploiting biochemical
mechanisms for physiological polymer synthesis to produce
bioink materials with enhanced physiological relevance may be
one approach to consider. Moreover, combining technologies
such as MESW and 3D bioprinting is possible, which provides
additional opportunities to mix synthetic and natural scaffolds
that create a tissue environment necessary for cell viability while
simultaneously providing structural support.
Besides optimization of hydrogel composition, the addition
of multiple cell types is challenging. Classically, fibroblasts and
keratinocytes represent in vitro skin, though in the current
era 3D skin constructs should be comprised of more than
two cell types. The incorporation of melanocytes is more
recently becoming commonplace due to the need for pigmented
skin constructs in the cosmetic industry (discussed in more
detail in the following chapter). Inappropriately, adipocytes,
neurons, Langerhans cells, etc., are not considered central to the
progression of in vitro 3D skin models. The microenvironments
necessary to support many of these cell types require further
investigation. Cells that reside within a specialized appendage,
such as sebocytes, require further optimization of biofabrication
techniques with respect to resolution of cell or polymer
positioning. The incorporation of these specialized cell types as
well as the fine-tuning of their respective microenvironments
may be feasible with a combination of bioprinting and MESW.
Furthermore, obtaining such specialized cells is an added
challenge. Primary keratinocytes and fibroblasts can be easily
isolated from “healthy” or diseased biopsies using standardized
protocols, whereas specialized cells (e.g. Merkel cells) are fewer
in number and lack specific isolation protocols. Progenitor cells
may be an alternative, though use of stem cells harbors additional
drawbacks such as extensive differentiation protocols with little
standardization and the potential for inadequate phenotypes.
Moreover, following the optimization of the hydrogel and
incorporation of all relevant cell types, the necessary appendages
andmacro-structures are still an added challenge. An appropriate
vasculature with capillary structure to provide an in vitro
environment that supplies oxygen and nutrients, and elimination
of waste products in a physiological manner is necessary.
Biofabrication techniques are critical for the development of
these structures and while some techniques exist and facilitate
the production of vascular skin models, there is yet to be
a technique to produce vessels of capillary scale efficiently
and with simultaneous cellularization and hydrogel fabrication.
Specifically, MESW and 3D bioprinting have a great potential
to produce adaptable physiological models with perfused
vasculature and 3D macrostructures (Figure 2). In addition,
defining an appropriate nutrient medium suitable for this
method of tissue culture will be necessary to maintain the
viability and differentiated state of cells for the duration of
growth and experimentation. Despite the complex challenges,
technologies are ever advancing and show great promise for
the production of reproducible physiological 3D skin constructs
with biocompatible and functional extracellular matrix, 3D
microstructures, as well as perfused vasculature and lymphatics
specifically for the in vitro identification and validation of
personalized medicines (Figure 2).
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FIGURE 2 | The interfaces at which biofabrication techniques enable the production of 3D physiological skin in vitro. Biofabrication techniques can function
independently for a traditional purpose, but also in combination with other techniques to produce specialized structures. Bioprinting is specifically designed for the
production of reproducible tissue constructs and precision positioning of cells. Electrospinning is designed for the production of functional tissues and use of
biocompatible materials. New technologies should focus on the production of 3D microstructures. Where electrospinning and bioprinting meet we can create
physiological extracellular matrix, while at the interface between electrospinning and new technologies is the ability to regulate tissue structure and mechanical
properties as well as the production of vascular networks and adaptable microenvironments. The interface of bioprinting and new technologies would enable the
production of 3D skin constructs with adaptable physiology for modeling disease and the possibility for preclinical testing of personalized medicines. Together the
current technologies, bioprinting and electrospinning, as well as novel technologies can easily produce affordable 3D skin constructs that mimic physiology.
SKIN DISEASE MODELS IN 3D
Use of 3D Skin Models for Disease
Skin diseases are among the most prevalent and largest burdens
of disease globally. The predominant types of skin diseases
include fungal diseases, subcutaneous diseases, acne vulgaris,
pruritus, eczema, impetigo, molluscum contagiosum/warts, and
scabies (Hay et al., 2014). Currently, the primary means of
identifying therapeutics for these diseases require the use of
animal models (Avci et al., 2013), increasing not only the
cost of drug development, but also the cost for consumers. In
addition to the financial burden, ethical concerns encourage
the development of in vitro 3D skin disease models such
as the implementation of the 3R principles (Tornqvist et al.,
2014). However, physiological interaction between keratinocytes,
fibroblasts, immune cells, adipocytes and many other cell types
are critical for the creation of physiological 3D skin constructs
that can be easily adapted for disease modeling and personalized
medicine.
Current 3D Skin Disease Models
Tissue damage, specific to the skin barrier, is the major source
of infection and onset of disease. The skin can be damaged
physically by blunt force, exposure to radiation, or by other
means of dysfunction including but not limited to genetic
and nutritional factors. The main types of disease models
currently investigated include wound models, infection, cancer,
and inflammation.
Presently, 3D skin models are used to both promote in vivo
wound healing as a skin substitute (Curran and Plosker, 2002),
and to identify crucial processes involved in typical wound
healing (Egles et al., 2010). Chronic skin wounds, ulcers,
demonstrate impaired healing and are typically associated with
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diabetes. In diabetic foot ulcers, increased Langerhans cells
(Stojadinovic et al., 2013; Strom et al., 2014), dermalmacrophages
(Loots et al., 1998), and neutrophils (Vatankhah et al., 2017)
positively correlate with disease severity in humans. Moreover,
the importance for adipose tissue to promote closure of non-
diabetic skin wounds was recently demonstrated in drosophila
(Franz et al., 2018). Yet, currently the investigation of wound
healing in 3D skin models is limited to wound closure by
fibroblasts and keratinocytes. Thus, the incorporation of resident
and circulating immune cell types as well as physiologically
relevant delivery of nutrients are necessary to recapitulate
diseases associated with chronic skin wounds. Furthermore, the
growth of the resident dermal bacteria, Staphylococcus aureus
(S. aureus) (Popov et al., 2014), as well as pathogenic bacteria,
Acinetobacter baumannii (de Breij et al., 2012), have been
established on uninjured 3D skin equivalents, and drug resistant
strains of S. aureus have also been used in a wound infection
model for therapeutic development (Ventress et al., 2016). The
physiological relevance of 3D skin wound models (diabetic
ulcers or chronic wounds) can progress with the addition of
today’s bioengineering techniques. Although, skin bioprinting is
currently used to produce skin equivalents for in vivo wound
treatment (summarized in a recent review; He et al., 2018), the
technology has thus far not been applied to generate in vitro skin
woundmodels. Still, it is clear that the bioprinting technology will
have a substantial impact on development of in vitro skin wound
models.
Prolonged and excessive sun exposure, and consequently,
exposure to UV radiation (UVR) can irreversibly damage
skin. This form of skin damage, photodamage, is a result of
UVR-induced biochemical and structural changes in skin and
manifests in a broad range of outcomes, from acute sunburn
to chronic aging-related disease such as actinic keratosis, and
further to cancers including melanoma and non-melanoma skin
cancer. Animal models of photodamaged skin require high doses
of UVR or prolonged exposures (Krishnasamy et al., 2017)
that include strict ethical regulations and therefore the use of
in vitro 3D skin models is gaining interest for these studies
(Fernandez et al., 2014) (including that of commercially available
skin equivalents such as MatTek EpiDermTM; Gruber et al.,
2018). Skin cancers range from basal cell carcinoma to squamous
cell carcinoma, as well as melanoma, and are one of the most
common cancers for Caucasian people worldwide. Skin cancers
are associated with photodamaged tissue and genetic mutations
in proteins of the Sonic Hedgehog pathway (PTCH1, SMO),
the mitogen-activated kinase pathway (RAS, RAF) and tumor
suppressor gene p53 (Wei et al., 2015). These pathways are also
associated with wound healing, due to regulation of proliferation
and cell migration. Hill et al. recapitulated an invasive melanoma
using rat melanoma cells in a 3D skin equivalent, thus
demonstrating the current feasibility of introducing primary cells
into a 3D skin model in vitro (Hill et al., 2015). Marconi et al.
have demonstrated the importance of cell-cell and cell-ECM
interactions in a 3D skin model of melanoma (Marconi et al.,
2018). Moreover, modeling these cancers in reproducible and
physiological 3D skin constructs would improve personalized
drug screening. The use of patient-specific induced pluripotent
stem cells (iPSCs) in the biofabrication of a 3D skin equivalent
whereby each cell type is indicative of the patient has been
demonstrated for normal skin tissue (Itoh et al., 2013; Gledhill
et al., 2015) as well as for epidermolysis bullosa (Itoh et al.,
2011). Alternatively, retroviral transfection can be used for
reprogramming of somatic cells to pluripotent cells for the
generation of diverse cell types though this might result in cell
transformation and caution should be taken with respect to
clinical use (Dixit et al., 2017). Stem cells have been bioprinted
with high survivial rates to reproduce liver, cardiac and cartilage
tissues after differentiation (Faulkner-Jones et al., 2015; Nguyen
et al., 2017; Ong et al., 2017). The main challenge regarding
bioprinting of stem cells is not the printing process itself, but
rather providing the appropriate mechanical and biochemical
cues that promote the specific differentiation and generation of
the corresponding tissue-specific lineage.
All skin diseases from wounds to photodamage, and cancer
to specific inflammatory diseases including psoriasis, dermatitis
and scleroderma have characteristic inflammatory profiles. In an
attempt to create a 3D skin equivalent that mimics inflammatory
disease, researchers have integrated several immune cell types
such as human CD4+ T cells (van den Bogaard et al.,
2014), Jurkat T cells (Kuhbacher et al., 2017), Langerhans
derived MUTZ-3 transformed cells (Ouwehand et al., 2012;
Kosten et al., 2015), primary isolated dendritic cells (Bechetoille
et al., 2011; Chau et al., 2013; Saalbach et al., 2015), and
human epidermis-derived macrophages (Bechetoille et al., 2011).
The incorporation of neurons and adipocytes also provide
an additional aspect of immune and disease modeling in
3D skin equivalents. Vidal et al. produced a full thickness
3D skin construct containing human induced neuronal stem
cells within an adipose scaffold hypodermis layer to model
an immune-competent skin equivalent (Vidal et al., 2018).
Moreover, the hydrogel composition may influence immune
responses in vitro. Lohmann et al. demonstrated that hydrogels
composed of star-shaped PEG and heparin (a type of GAG)
are able to bind chemokines by electrostatic interactions. This
hydrogel worked as an effective chemokine scavenger and
reduced inflammatory processes in an in vivo model of delayed
wound healing in mice (Lohmann et al., 2017). Likewise, an
immune-competent hydrogel comprised of both a hypodermis
containing lipoaspirate (adipocytes, pre-adipocytes, endothelial
cells, smooth muscle cells, and macrophages) and human
induced neural stem cells was fabricated, from which time-
dependent inflammatory responses were observed (Vidal et al.,
2018).
Outlook of Skin Disease Models in 3D
It is important to consider the benefit of 3D skin constructs when
modeling skin diseases in vitro. For example, the incorporation
of relevant cell types that influence wound healing in vivo
such as Langerhans cells, dermal macrophages, neutrophils, and
adipocytes are necessary. Hence, the classic in vitro skin models
cannot be used to model physiological wounds. Moreover,
assessment of drugs or wound dressings in the current in vitro
models is inadequate or impractical.
With respect to the incorporation of cell types into 3D
skin models, several commercially available skin models have
been developed that include melanocytes (e.g. MelanoDermTM,
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MatTek corp.; epiCS R©-M, ATERA SAS & CellSystems Gmbh;
and SkinEthic TM RHPE, EPISKIN, subsidiary of L’Oreal) for the
testing of sun care products. Biedermann et al. demonstrated that
melanocytes seeded in a 3D skin model retain their phenotype
(expression of BCL2, SOX9, and MITF) for over 15 weeks
after transplantation onto immune-incompetent rats, which has
important clinical implications for matching transplanted skin
with patient skin color (Biedermann et al., 2015). Additionally,
the presence of melanocytes is crucial for the investigation of
vitiligo that has yet to be modeled in vitro.
Nevertheless, the infiltration of leukocytes, such as non-
resident macrophages and granulocytes, from vasculature into
the hydrogel has yet to be established. This would require
development of a perfusion system that includes vasculature
and lymphatic networks as was aforementioned regarding
physiological nutrient and waste transport. What is more, disease
models should include the incorporation of hair, glands, and
tactile corpuscles. To date, these macro-structures/appendages
are absent in 3D skin equivalents but are significant for
developing models of in vitro diseases that are currently only
modeled in animals, such as alopecia and acne vulgarus.
In this regard, bioprinting technology holds great promise
in the development of diseased skin models. In addition,
the incorporation of peptides that illicit immune responses
or promote matrix degradation mimicking disease may be
possible with electrospinning techniques. First and foremost,
the challenge remains for the technology to produce improved
healthy skin models with all of these components with the
production efficiency of the standard casting technology.
THE FUTURE OF 3D SKIN FABRICATION
IN VITRO
Current technologies with respect to 3D tissue fabrication
facilitate the automated production of reproducible and
functional skin tissue. For instance, biofabrication techniques
already enable the production of large-scale pigmented skin
transplants in the range of 100 cm2 (Min et al., 2018). In addition,
commercially available constructs for in vivo applications exist
such as Apligraf R© (Eaglstein and Falanga, 1998), Theraskin R©,
Dermagraft (Hart et al., 2012), and OrCel R© and in vitro
applications such as EpiSkin (EPISKIN SA a subsidiary of
L’Oreal) (Roguet et al., 1994), EpidermTM (MatTek Corp.)
(Cannon et al., 1994), Leiden epidermal skin model and Fully
Human SkinModel (Biomimiq a division of Aeon Astron Europe
B.V.), EpiCS R© RHE (CellSystems R© GmbH and ATERA SAS)
and LabCyte EPI-MODEL (Japan Tissue Engineerging Co., Ltd.).
With that being said, it is evident that collaborations between
industry and academia can further progress the development of
these models toward a more physiologically relevant construct
and encourage their use in basic science to replace 2D tissue
culture.
Moreover, challenges in the production and use of 3D skin
models for basic science lies in affordability. Both bioprinting
and electrospinning not only enable the ease of production of
such constructs but also contribute to low-cost strategies for
development of 3D skin tissues. Bioprinting and electrospinning
have already been used in combination instruments, though the
addition of new technologies for use in tandem may aid in
the production of vasculature, appendages, and constructs easily
modulated for disease modeling (Figure 2).
Toward a More Relevant in vitro 3D Skin
Model
Although standard 3D skin models are a major improvement
when compared to 2D culture, their minimalism still does not
yet reflect the in vivo situation. Key areas necessary to produce
a more relevant 3D skin model include: (1) the creation of
a well-defined physiological matrix and microenvironment, (2)
inclusion of additional specialized cell types, and (3) ease of
production with new fabrication techniques.
Producing well-defined physiological matrix
components goes further than collagen and fibrin. These
proteins and fibers are highly modified by post-translational
modifications each of which possesses specific functionalities.
Therefore, although combinations of commercially available
collagen and other natural or synthetic polymers appears to be
the strategy of many researchers, alternative methodology for
the production of physiological matrices should be considered.
Perhaps, similarly to CRISPR technologies, a biochemical
mechanism can be exploited to fabricate physiological matrix
with appropriate post-translational modifications that is also
compatible with bioprinting technologies. Such an angle might
be the use of isolated endoplasmic reticulum programmed to
produce collagens and elastins that is bioprinted within a scaffold
support.
The formation of physiologically relevant microenvironments
adds additional complexity as it is difficult to measure such
parameters in vivo. Additional research to identify the ideal
culture conditions for sebocytes, isolated glands, and hair follicles
can give us inklings into the microenvironments necessary to
recapitulate within a 3D printed skin construct. Meanwhile,
the integration of vasculature-like structures lends to the
optimization of physiological nutrient and oxygen delivery
as well as waste product removal. These are already rapidly
advancing due to electrospinning and bioprinting, though with
the addition of new novel techniques that can be combined with
bioprinting, the ease of production can improve.
As mentioned briefly above, the addition of specialized
cell types (e.g. sebocytes, Merkel cells etc.) may promote the
sustained culture of 3D skin constructs in vitro. Addition of
inflammatory cells goes beyond the need to recapitulate disease.
Specifically resident tissue macrophages are responsible for the
clearing of terminated cells that may otherwise result in a
decline in overall tissue health if left unresolved. Therefore, these
cells are required when producing healthy and physiologically
relevant skin constructs to sustain the overall health of the tissue
during culturing. 3D printing can facilitate in the placement
and inclusion of such cell types into 3D skin constructs at
present, thus sustainable tissue culture of 3D skin constructs is
in the immediate future. Furthermore, the spatial positioning
provided by biofabrication techniques can enable the production
of appendages and macrostructures within skin tissue that
include these specialized cell types for the formation of glands
and hair follicles.
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Each aspect of physiological skin is possible with current
biofabrication techniques or the development of novel
techniques with a specific purpose and compatibility with
current technologies (Figure 2). For one, the combination of
MESW and 3D bioprinting is becoming more commonplace
and the first commercially available bioprinters are on the
market. The integration of additional electrospinning techniques
such as cryo-electrospinning, salt leaching electrospinning,
cold-plate electrospinning, emulsion electrospinning or air flow
electrospinning may also be promising for the production of
specific structural components. Moreover, the development
of novel printheads for multipurpose bioprinting is optimal.
Novel technologies being developed at present should consider
the ability to be integrated for use with other technologies and
not as a stand-alone product. This will aid in the ease of tissue
production and cost-effectiveness of such tissues (Figure 2).
Future Perspective
The development and evolution of in vitro 3D skin tissue
over the past 70 years provides skin models that can replace
the need for animal experimentation in pre-clinical testing
and advances the capabilities for personalized medicine.
Unfortunately, with respect to production of 3D skin, we
still face many of the same issues that troubled scientists in
the middle of the twentieth century, including physiological
oxygen and nutrient delivery with a perfused vasculature,
complex structures such as glands and tactile corpuscles, as
well as readily accessible and reproducible constructs for use
in research laboratories. Furthermore, sustained tissue culture
and skin disease modeling will become a reality once immune-
competent cells are successfully integrated, both into hydrogels
as well as within a circulating vasculature. The convergence
of different biofabrication techniques, such as bioprinting
and electrospinning will address not only the incorporation of
immune cells into the skinmodel, but also appendages to increase
the ability for one to create a physiological skin for personalized
medicine and other pre-clinical applications (e.g. drug testing)
(Figure 2). The production of necessary physiologically
relevant skin components from ECM to microbiome are
feasible with current bioengineering technologies, though
additional advancements to existing technologies and
development of completely novel technologies will provide
cost-effective and reproducible generation of physiological skin
in vitro.
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